About Georgia McCann, M.D.
Dr. Georgia McCann joined the faculty of the University of Texas Health Science Center San Antonio in 2013. She is an associate clinical professor in the Division of Gynecologic Oncology. Her expertise includes the diagnosis, treatment and research of cervical, endometrial, ovarian and vulvar cancers. Dr. McCann also has advanced surgical training in robotic and laparoscopic procedures, radical pelvic and reconstructive surgery, for the diagnosis and treatment of gynecologic cancers and complicated benign gynecologic conditions. She completed her gynecologic oncology fellowship at The Ohio State University Wexner Medical Center after a residency in obstetrics and gynecology at the Hospital of the University of Pennsylvania. Dr. McCann has authored or co-authored more than 35 papers published in peer reviewed journals. She also serves as the associate program director for the gynecologic oncology fellowship program and leads the gynecologic oncology clinical trial program.
In 2016, Dr. McCann founded the Purple Heals support group for women with gynecologic cancers, the first group of its kind in San Antonio. Dr. McCann looks forward to promoting the care of women with gynecologic cancers in South Texas.
Georgia McCann | Gynecologic Oncology
I believe in treating the whole patient and ensuring that all patients are active participants in their care.
- Associate Professor, Gynecologic Oncology, University of Texas Health Science Center San Antonio
- American Board of Obstetrics & Gynecology, Gynecologic Oncology
- Medical School: Thomas Jefferson Medical College, Philadelphia, PA
- Residency: University of Pennsylvania, Philadelphia, PA
- Fellowship: The Ohio State University, Columbus, OH
- Locations & Contact
Research & Publications
Research & Publications
Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative Complications.
Backes FJ, Rosen M, Liang M, McCann GA, Clements A, Cohn DE, OʼMalley DM, Salani R, Fowler JM.
Int J Gynecol Cancer. 2015 Sep;25(7):1271-6. doi: 0.1097/IGC.0000000000000480. PubMed PMID: 26017249.
Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor.
McCann GA, Naidu S, Rath KS, Bid HK, Tierney BJ, Suarez A, Varadharaj S, Zhang J, Hideg K, Houghton P, Kuppusamy P, Cohn DE, Selvendiran K.
Oncoscience. 2014 Mar 31;1(3):216-28. eCollection 2014. PubMed PMID: 25594014; PubMed Central PMCID: PMC4278289.
Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis.
McCann GA, Cohn DE, Jewell EL, Havrilesky LJ.
Gynecol Oncol. 2015 Feb;136(2):300-4. doi: 10.1016/j.ygyno.2014.11.079. Epub 2014 Dec 2. PubMed PMID: 25478927.
ClinicalTrials.gov registration not required
Georgia McCann M.D.
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk] (CTMS# 21-0114)